Retour
Fourchette du Jour
3,37 €
3,57 €
Fourchette 52 Semaines
1,15 €
6,75 €
Volume
5 301 410
Moyenne 50J / 200J
3,80 €
/
4,04 €
Clôture Précédente
3,49 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,3 | 0,4 |
| P/B | 5,5 | 2,9 |
| ROE % | -83,1 | 3,7 |
| Net Margin % | -48464,0 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
11,75 €
+246.6%
Low: 10,00 €
High: 14,00 €
BPA Prévisionnel
-0,48 €
CA Est.
470000
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,23 €
0,23 € – 0,23 €
|
440 M | 4 |
| FY2029 |
-0,26 €
-0,26 € – -0,26 €
|
190 M | 4 |
| FY2028 |
-0,47 €
-0,77 € – -0,29 €
|
20 M | 10 |
Points Clés
Debt/Equity of 0,21 — conservative balance sheet
Negative free cash flow of -82,53M
Capital intensive — 30,84% of revenue goes to capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)-1,91%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-83,10%
ROIC-54,62%
Net Margin-48463,96%
Op. Margin-33341,23%
Sécurité
Debt / Equity
0,21
Current Ratio3,21
Interest Coverage-32,87
Valorisation
P/E Ratio
-4,28
P/B Ratio5,50
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,91% | Revenue Growth (3Y) | 14,97% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 308 000,0 | Net Income (TTM) | -149,27M |
| ROE | -83,10% | ROA | -93,65% |
| Gross Margin | 100,00% | Operating Margin | -33341,23% |
| Net Margin | -48463,96% | Free Cash Flow (TTM) | -82,53M |
| ROIC | -54,62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,21 | Current Ratio | 3,21 |
| Interest Coverage | -32,87 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,28 | P/B Ratio | 5,50 |
| P/S Ratio | 2076,10 | PEG Ratio | -0,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 639,44M | Enterprise Value | 646,64M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 308 000,0 | 314 000,0 | 233 000,0 | 20,38M | 0,0 |
| Net Income | -149,27M | -40,22M | -152,39M | -167,81M | -169,84M |
| EPS (Diluted) | -0,93 | -0,25 | -0,91 | -0,83 | -0,67 |
| Gross Profit | 308 000,0 | 314 000,0 | 233 000,0 | 20,38M | 0,0 |
| Operating Income | -102,69M | -125,47M | -144,79M | -135,81M | -104,16M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 159,39M | 293,48M | 305,44M | 414,17M | 111,55M |
| Total Liabilities | 42,83M | 49,16M | 39,68M | 28,21M | 16,18M |
| Shareholders' Equity | 116,30M | 242,96M | 260,74M | 376,91M | 90,82M |
| Total Debt | 24,71M | 19,14M | 15,34M | 743 000,0 | 2,18M |
| Cash & Equivalents | 17,51M | 45,03M | 190,61M | 362,27M | 97,25M |
| Current Assets | 80,13M | 185,59M | 287,15M | 375,08M | 99,55M |
| Current Liabilities | 24,95M | 20,12M | 19,90M | 20,94M | 12,30M |